Pharmacogenetics of drug-resistant epilepsy (review of literature)

B Smolarz, M Makowska, H Romanowicz - International journal of …, 2021 - mdpi.com
Pharmacogenomic studies in epilepsy are justified by the high prevalence rate of this
disease and the high cost of its treatment, frequent drug resistance, different response to the …

Drug-Resistant Epilepsy and Gut-Brain Axis: an Overview of a New Strategy for Treatment

S Chen, Y Jiao, C Han, Y Li, W Zou, J Liu - Molecular Neurobiology, 2023 - Springer
Abstract Drug-resistant epilepsy (DRE), also known as intractable epilepsy or refractory
epilepsy, is a disease state with long-term poorly controlled seizures attack. Without effective …

CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride

DM Campodónico, P Zubiaur… - Clinical and …, 2022 - Wiley Online Library
Cinitapride is a gastrointestinal prokinetic drug, prescribed for the treatment of functional
dyspepsia, and as an adjuvant therapy for gastroesophageal reflux disease. In this study, we …

The hidden dangers of short-term glucocorticoid use in children: A genomic analysis

X Xu, Y Li, T Han, Y Zhao, X Wang, X Fu… - International …, 2024 - Elsevier
Objective Glucocorticoid (GC) administration has been associated with adverse drug
reactions (ADRs) affecting multiple organ systems. While long-term use is widely recognized …